[1] Xu W, Lu H, Zhu Y, et al. Warthin's tumour in oral and maxillofacial regions: an 18-year retrospective study of 1084 cases in an eastern-Chinese population [J]. Int J Oral Maxillofac Surg, 2018, 47(7):913-917. [2] Kadletz L, Grasl S, Perisanidis C, et al. Rising incidences of Warthin's tumors may be linked to obesity: a single-institutional experience [J]. Eur Arch Otorhinolaryngol, 2019, 276(4):1191-1196. [3] Psychogios G, Vlastos I, Thölken R, et al. Warthin's tumour seems to be the most common benign neoplasm of the parotid gland in Germany [J]. Eur Arch Otorhinolaryngol, 2020, 277(7): 2081-2084. [4] 张志愿.口腔颌面外科学[M].北京:人民卫生出版社.2020.223. [5] Tunç O, Gönüldaş B, Arslanhan Y, et al. Change in Warthin's tumor incidence: a 20-year joinpoint trend analysis [J]. Eur Arch Otorhinolaryngol, 2020, 277(12):3431-3434. [6] Franzen AM, Kaup Franzen C, Guenzel T, et al. Increased incidence of Warthin tumours of the parotid gland: a 42-year evaluation [J]. Eur Arch Otorhinolaryngol, 2018, 275(10):2593-2598 [7] WHO.Tobacco [EB/OL].2017.http://www.who.int/mediacentre/factsheets/fs339/en/ [8] 狄翠萍.河南省15岁及以上居民吸烟及饮酒现况研究 [D].郑州大学,2019. [9] Kuzenko YV, Romanuk AM, Dyachenko OO, et al. Pathogenesis of Warthin’s tumors [J]. Interv Med Appl Sci, 2016, 8(2):41-48. [10] 俞光岩,柳晓冰,李自力.吸烟与腮腺沃辛瘤的发病[J].中华口腔医学杂志,1995,30(4):195-197. [11] 陈飞,王利伟,布静秋.腮腺沃辛瘤555例临床分析[J].北京口腔医学,2022,30(4):284-286. [12] Seifert G. Bilateral mucoepidermoid carcinomas arising in bilateral pre-existing Warthin’s tumors of the parotid gland [J]. Oral Oncol, 1997, 33(4):284-287. [13] Winnes M, Enlund F, Mark J, et al. The MECT1- MAML2 gene fusion and benign Warthin’s tumor [J]. J Molr Diagn, 2006, 8(3): 394-396. [14] Martins C, Cavaco B, Tonon G, et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands [J]. J Mol Diagn, 2004, 6(3):205-210. [15] Borsetto D, Fussey JM, Cazzador D, et al. The diagnostic value of cytology in parotid Warthin's tumors: international multicenter series [J]. Head Neck, 2020, 42(3):522-529. |